Vardenafil Unknown Status Phase 4 Trials for Pulmonary Arterial Hypertension (PAH) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00705588Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
NCT01649739Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost